Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (191-200 of 320) with videos related to

Pageof 32
Sort By:
New Solutions : a Journal of Environmental and Occupational Health Policy : NS|May 26, 2026
Rationale for Accreditation Criteria for the MATES in Construction Workplace Suicide Prevention ProgramAnthony D LaMontagne, Tania King, Jorgen Gullestrup, et al.
Journal of Lipid Research|April 17, 2020
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDLM John Chapman, Alexina Orsoni, Ricardo Tan, et al.
Transfusion|July 19, 2003
West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivationThomas Mather, Tsutomu Takeda, Jodie Tassello, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 31, 2002
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosisGabriel Perlemuter, Abdelmajid Sabile, Philippe Letteron, et al.
Atherosclerosis|January 24, 2012
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapyNatacha Bellanger, Zélie Julia, Elise F Villard, et al.
Current Medical Research and Opinion|March 31, 2011
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)Stephen J Nicholls, Marilyn Borgman, Steven E Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBVasilis Tsimihodimos, Sonia-Athena P Karabina, Afroditi P Tambaki, et al.
Atherosclerosis|March 25, 2014
Premature atherosclerosis is not systematic in phytosterolemic patients: severe hypercholesterolemia as a confounding factor in five subjectsBoris Hansel, Alain Carrié, Nathalie Brun-Druc, et al.
Journal of Learning Disabilities|September 26, 2013
Academic Achievement Among Juvenile DetaineesElena L Grigorenko, Donna Macomber, Lesley Hart, et al.
Circulation|March 25, 2009
Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stageEmmanuel L Gautier, Thierry Huby, Joseph L Witztum, et al.
Pageof 32

Showing results (191-200 of 320) with videos related to

Sort By:
Pageof 32
New Solutions : a Journal of Environmental and Occupational Health Policy : NS|May 26, 2026
Rationale for Accreditation Criteria for the MATES in Construction Workplace Suicide Prevention ProgramAnthony D LaMontagne, Tania King, Jorgen Gullestrup, et al.
Journal of Lipid Research|April 17, 2020
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDLM John Chapman, Alexina Orsoni, Ricardo Tan, et al.
Transfusion|July 19, 2003
West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivationThomas Mather, Tsutomu Takeda, Jodie Tassello, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 31, 2002
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosisGabriel Perlemuter, Abdelmajid Sabile, Philippe Letteron, et al.
Atherosclerosis|January 24, 2012
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapyNatacha Bellanger, Zélie Julia, Elise F Villard, et al.
Current Medical Research and Opinion|March 31, 2011
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)Stephen J Nicholls, Marilyn Borgman, Steven E Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBVasilis Tsimihodimos, Sonia-Athena P Karabina, Afroditi P Tambaki, et al.
Atherosclerosis|March 25, 2014
Premature atherosclerosis is not systematic in phytosterolemic patients: severe hypercholesterolemia as a confounding factor in five subjectsBoris Hansel, Alain Carrié, Nathalie Brun-Druc, et al.
Journal of Learning Disabilities|September 26, 2013
Academic Achievement Among Juvenile DetaineesElena L Grigorenko, Donna Macomber, Lesley Hart, et al.
Circulation|March 25, 2009
Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stageEmmanuel L Gautier, Thierry Huby, Joseph L Witztum, et al.
Pageof 32